Prof. Tamar Geiger

Our lab studies tumor heterogeneity using cutting-edge mass spectrometry-based proteomics of cancer clinical samples. We combine proteomic method development with bioinformatics and experimental validation in order to investigate the relation between the cancer cells and the immune system within the tumor microenvironment, and specifically in the context of immunotherapy response. Furthermore, we investigate the association between the proteomic level and the genomic and transcriptomic levels aiming to elucidate gene-expression regulatory mechanisms and the functional proteomic output of cancer somatic mutations.